Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 2, Issue 11, Pages 919-928Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd1230
Keywords
-
Ask authors/readers for more resources
In this article, we discuss the challenges, recent developments and new thinking on drug R&D for neglected diseases through public-private partnerships. The focus on virtual drug discovery and development as operationalized through these partnerships brings many advantages, as well as scientific and managerial challenges. Some are common to those faced by all drug R&D ventures. Others, for example the need for drugs with a very low cost of manufacture that are easy to use in resource-poor environments and an active engagement in disease-endemic countries, are unique to this novel paradigm.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available